INOZYME PHARMA INC. -
5.2100
07-أكتوبر-24 15:59:31
15 متأخرة بدقائق
الأسهم
+0.0400
+0.77%
نطاق اليوم
5.1200 - 5.2800
ISIN
N/A
المصدر
NASDAQ
-
07 أكتوبر 2024 08:30:17 بحسب Nasdaq GlobeNewswire
-
26 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
29 أغسطس 2024 08:30:23 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
06 أغسطس 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
25 يوليو 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
02 يوليو 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
21 يونيو 2024 13:00:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
30 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
23 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
08 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
07 مايو 2024 08:30:44 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مايو 2024 08:30:02 بحسب Nasdaq GlobeNewswire
-
08 أبريل 2024 06:30:35 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 أبريل 2024 18:00:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
02 أبريل 2024 08:30:03 بحسب Nasdaq GlobeNewswire
-
26 مارس 2024 08:30:42 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
12 مارس 2024 08:30:16 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
26 فبراير 2024 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 فبراير 2024 08:30:48 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 ديسمبر 2023 08:30:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >